Description and Brand Names
Drug information provided by: IBM Micromedex
US Brand Name
Nivolumab and relatlimab-rmbw combination injection is used to treat melanoma (skin cancer) that has spread throughout the body (metastatic) or that cannot be removed by surgery.
This medicine is to be given only by or under the supervision of your doctor.
This product is available in the following dosage forms:
Portions of this document last updated: Feb. 01, 2023
Copyright © 2023 IBM Watson Health. All rights reserved. Information is for End User's use only and may not be sold, redistributed or otherwise used for commercial purposes.